Drugs / GXCPC1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03943576 | Dec 2019 → Apr 2022 | osteoarthritis, knee | Gwo Xi Stem Cell Applied Technology Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GXCPC1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03943576 ↗ |
| Modality | Cell therapy | “Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells (GXCPC1) for Knee Osteoarthritis” NCT03943576 ↗ |
| Route | Other | “one single intra-articular injection of GXCPC1” NCT03943576 ↗ |